32 Included patients were matched for age, sex, race and ethnicity, cardiovascular diseases, DR severity (including PDR and DME status), history of tobacco use, body mass index, and hemoglobin A1c percentage
Its a nickname used to describe sudden vision loss that may be linked to the weight loss drugs semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)
These drugs are also being tested to treat other conditions, and the FDA has just approved a new use for Wegovy to reduce the risk of adverse cardiovascular events
Lets look at what makes you eligible and the health factors that matter
These varied strategies reflect the market's evolution beyond simple medication access toward comprehensive weight management ecosystems
Syed designs a fully personalized weight loss plan integrating the most appropriate combination of GLP-1 medications, nutritional guidance, exercise recommendations, and behavioral coaching